<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="ribavirin/PMC3764029/results/search/disease/results.xml">
  <result pre="ribavirin mono-therapy regimens have minimal effect on patients with chronic" exact="hepatitis" post="C virus (HCV) infections, they can be efficacious when"/>
  <result pre="NS5B) (reviewed in reference [1]). Human HCV infection causes chronic" exact="liver disease," post="cirrhosis, and is associated with hepatocellular carcinoma [2]. It"/>
  <result pre="infection causes chronic liver disease, cirrhosis, and is associated with" exact="hepatocellular carcinoma" post="[2]. It is estimated that 180 million people worldwide"/>
  <result pre="infection it is expected that the number of patients with" exact="hepatocellular carcinoma" post="will increase in the coming years. The standard therapy"/>
  <result pre="[13]. 5-Fluorouracil is broadly used in the clinic to treat" exact="cancer" post="[14] including HCV associated hepatocellular carcinoma [15]. 5-Fluorouracil displays"/>
  <result pre="in the clinic to treat cancer [14] including HCV associated" exact="hepatocellular carcinoma" post="[15]. 5-Fluorouracil displays mutagenic activity leading to viral extinction"/>
  <result pre="MarinosG, et al. (2002) Peginterferon alfa-2a plus ribavirin for chronic" exact="hepatitis" post="C virus infection. N Engl J Med347: 975–982doi:;10.1056/NEJMoa020047;347/13/97512324553 5ShermanKE,"/>
  <result pre="NelsonDR, SulkowskiMS, et al. (2011) Response-guided telaprevir combination treatment for" exact="hepatitis" post="C virus infection. N Engl J Med365: 1014–1024doi:10.1056/NEJMoa101446321916639 6LimayeAR,"/>
  <result pre="tegobuvir alone, with ribavirin, or pegylated interferon plus ribavirin in" exact="hepatitis" post="C. Hepatology. 55: 749–758doi:10.1002/hep.24744 8ZeuzemS, AsselahT, AngusP, ZarskiJP, LarreyD,"/>
  <result pre="(2008) Mechanisms of action of interferon and ribavirin in chronic" exact="hepatitis" post="C: Summary of a workshop. Hepatology47: 306–320.18161743 10FeldJJ, LutchmanGA,"/>
  <result pre="EvansMJ, SyderAJ, WolkB, TellinghuisenTL, et al. (2005) Complete replication of" exact="hepatitis" post="C virus in cell culture. Science309: 623–626.15947137 12FeigelstockDA, MihalikKB,"/>
  <result pre="cell culture. Science309: 623–626.15947137 12FeigelstockDA, MihalikKB, FeinstoneSM (2011) Selection of" exact="hepatitis" post="C virus resistant to ribavirin. Virol J 8402: 1743–422X-8-402doi:10.1186/1743-422X-8-402"/>
  <result pre="survival to intraarterial 5-fluorouracil/interferon combination therapy in patients with advanced" exact="hepatocellular carcinoma." post="J Gastroenterol42: 845–853doi:10.1007/s00535-007-2099-817940838 16MorenoH, TejeroH, de la TorreJC, DomingoE,"/>
  <result pre="MorelV, WychowskiC, et al. (2007) Effect of ribavirin on the" exact="hepatitis" post="C virus (JFH-1) and its correlation with interferon sensitivity."/>
  <result pre="are region specific and increased by ribavirin in a full-length" exact="hepatitis" post="C virus replication system. J Virol76: 8505–8517.12163570 25HofmannWP, PoltaA,"/>
  <result pre="MihmU, KronenbergerB, et al. (2007) Mutagenic effect of ribavirin on" exact="hepatitis" post="C nonstructural 5B quasispecies in vitro and during antiviral"/>
  <result pre="YokosukaO, ImazekiF, TanakaM, ShinoY, et al. (2004) Inhibition of subgenomic" exact="hepatitis" post="C virus RNA in Huh-7 cells: ribavirin induces mutagenesis"/>
  <result pre="SongBC, LiangTJ, HoofnagleJH, et al. (2007) Mutation rate of the" exact="hepatitis" post="C virus NS5B in patients undergoing treatment with ribavirin"/>
  <result pre="Deep sequencing reveals mutagenic effects of ribavirin during monotherapy of" exact="hepatitis" post="C virus genotype 1-infected patients. J Virol 876172–6181: JVI.02778–12doi:10.1128/JVI.02778-12"/>
  <result pre="JacobsonI, GeorgeS (2008) Recent progress in the development of selected" exact="hepatitis" post="C virus NS3.4A protease and NS5B polymerase inhibitors. Current"/>
  <result pre="(2004) First clinical results for a novel antiviral treatment for" exact="hepatitis" post="C: a phase I/III dose escalation trial assessing tolerance,"/>
  <result pre="efficacy upon administration of a HepDirect prodrug of 2′-C-methylcytidine to" exact="hepatitis" post="C virus-infected chimpanzees. Antimicrob Agents Chemother 553854–3860: AAC.01152–10doi:10.1128/AAC.01152-10 36Le"/>
  <result pre="YoungKC, LaiMM (2003) Mutagenic and inhibitory effects of ribavirin on" exact="hepatitis" post="C virus RNA polymerase. Biochemistry42: 10462–10471.12950173 40SierraM, AiraksinenA, Gonzalez-LopezC,"/>
  <result pre="al. (1999) Crystal structure of the RNA-dependent RNA polymerase from" exact="hepatitis" post="C virus reveals a fully encircled active site. Nature"/>
  <result pre="Crystal structures of the RNA-dependent RNA polymerase genotype 2a of" exact="hepatitis" post="C virus reveal two conformations and suggest mechanisms of"/>
  <result pre="344–348.16327776 46TellinghuisenTL, MarcotrigianoJ, GorbalenyaAE, RiceCM (2004) The NS5A protein of" exact="hepatitis" post="C virus is a zinc metalloprotein. J Biol Chem"/>
  <result pre="EggerD, LohmannV, BartenschlagerR, BlumHE, et al. (2003) Identification of the" exact="hepatitis" post="C virus RNA replication complex in Huh-7 cells harboring"/>
  <result pre="protein into nonstructural protein 5A allows direct visualization of functional" exact="hepatitis" post="C virus replication complexes. J Virol78: 7400–7409.78/14/7400doi:10.1128/JVI.78.14.7400-7409.200415220413 49MacdonaldA, HarrisM"/>
  <result pre="al. (1995) Comparison of full-length sequences of interferon-sensitive and resistant" exact="hepatitis" post="C virus 1b. Sensitivity to interferon is conferred by"/>
  <result pre="Clin Invest96: 224–230doi:10.1172/JCI1180257542279 51HsuHH, DonetsM, GreenbergHB, FeinstoneSM (1993) Characterization of" exact="hepatitis" post="C virus structural proteins with a recombinant baculovirus expression"/>
 </snippets>
</snippetsTree>
